Trimonil Retard 300 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

trimonil retard 300 mg

desitin arzneimittel gmbh - karbamazepin - depottablett - 300 mg

Trimonil Retard 150 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

trimonil retard 150 mg

desitin arzneimittel gmbh - karbamazepin - depottablett - 150 mg

Trimonil Retard 600 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

trimonil retard 600 mg

desitin arzneimittel gmbh - karbamazepin - depottablett - 600 mg

Brintellix ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

brintellix

h. lundbeck a/s - vortioxetine - depressiv lidelse, major - psychoanaleptics, - behandling av alvorlige depressive episoder hos voksne.

Rydapt ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

rydapt

novartis europharm ltd - midostaurin - leukemia, myeloid, acute; mastocytosis - antineoplastiske midler - rydapt er angitt:i kombinasjon med standard daunorubicin og cytarabine induksjon og høy dose cytarabine konsolidering kjemoterapi, og for pasienter i komplett respons etterfulgt av rydapt enkelt agent vedlikehold terapi, for voksne pasienter med nylig diagnostisert med akutt myelogen leukemi (aml) som er flt3 mutasjonspositive (se kapittel 4. 2);som monoterapi for behandling av voksne pasienter med aggressiv systemiske mastocytosis (asm), og systemiske mastocytosis med tilhørende haematological neoplasm (sm ahn), eller mast celle leukemi (mcl).

Lanoxin 50 mikrog/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

lanoxin 50 mikrog/ ml

aspen pharma trading limited - digoksin - mikstur, oppløsning - 50 mikrog/ ml

Lanoxin 0.25 mg/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

lanoxin 0.25 mg/ ml

aspen pharma trading limited - digoksin - injeksjonsvæske, oppløsning - 0.25 mg/ ml

Nolvadex 20 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

nolvadex 20 mg

astrazeneca - tamoksifensitrat - tablett - 20 mg

Tamoxifen Viatris 20 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

tamoxifen viatris 20 mg

viatris limited - tamoksifensitrat - tablett - 20 mg

Tecovirimat SIGA ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

tecovirimat siga

siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - antivirale midler til systemisk bruk - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 og 5. tecovirimat siga should be used in accordance with official recommendations.